翻译通读药物及其在血友病治疗中的作用
摘要
无义突变是人类遗传性疾病的重要病因.翻译通读治疗通过促进阅读框中无义密码子通读而产生全长蛋白质,这为治疗包括血友病在内的多种无义突变引起的遗传性疾病带来了希望.本文将对基因翻译通读治疗药物的作用机制及其在血友病治疗中的作用进行综述.
出处
《国际输血及血液学杂志》
CAS
2010年第4期377-379,共3页
International Journal of Blood Transfusion and Hematology
基金
基金项目：山西省归国留学人员科研基金（2009重点7）
参考文献23
-
1Mendell JT,Dietz HC.When the message goes awry:diseaseproducing mutations that influence mRNA content and performance.Cell,2001,107(4),411-414.
-
2Silva AL,Romao L.The mammalian nonsense-mediated mRNA decay pathway:to decay or not to decay! Which players make the decision? FEBS Lett,2009,583(3):499-505.
-
3Lynch SR,Gonzalez RL,Puglisi JD.Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex.Structure,2003,11(1):43-53.
-
4Fan-Minogue H,Bedwell DM.Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity.RNA,2007,14(1):148-157.
-
5Burke JF,Mogg AE.Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-4 18 and paromomycin.Nucleic Acids Res,1985,13(17):6265-6272.
-
6Amrani N,Ganesan R,Kervestin S,et al.A faux 3 '-UTR promotes aberrant termination and triggersnonsense-mediated mRNA decay.Nature,2004,432(7013):112-118.
-
7Howard M,Frizzell RA,Bedwell NM.Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.Nat Med,1996,2(4):467-469.
-
8Rebibo-Sabbah A,Nudelman I,Ahmed ZM,et al.In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome.Hum Mol Genet,2007,122(3-4).373-381.
-
9Wolstencroft EC,Mattis V,Bajer AA,et al.A non-sequencespecific requirement for SMN protein activity:the role of aminoglycosides in inducing elevated SMN protein levels.Hum Mol Genet,2005,14(9):1199-1210.
-
10Linde L,Boelz S,Nissim-Rafinia M,et al.Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.J Clin Invest,2007,117(3):683-692.
-
1袁辉,江高峰,杜柳涛.无义突变通读药物研发进展[J].中国新药杂志,2017,26(8):893-898.
-
2别让药物伤了孩子[J].人人健康,2013(5):39-39.
-
3医药技术[J].经济导报（医药技术）,2007(2):3-3.
-
4杨祚培.新修订《药品管理法》尚待完善的几个地方[J].中国药师,2003,6(7):447-448. 被引量：4
-
5谢骁祥,袁辉,王震宇,程静,吴磊,杜柳涛,江高峰.无义突变型荧光素酶稳定表达细胞株的建立[J].药物分析杂志,2017,37(4):583-588.
-
6李懋,刘静.尿酸转运蛋白功能的研究进展[J].医学综述,2015,21(1):32-34. 被引量：1
-
7谢骁祥,江高峰,杜柳涛.基因治疗药物无义突变通读活性检测方法的研究进展[J].药物分析杂志,2016,36(10):1701-1705.
-
8申泉,张丽,柴宝峰.终止密码子位点及无义突变介导的mRNA降解途径抑制对抗早发性无义突变药物atalruen通读效率的影响[J].中国药物与临床,2015,15(3):297-300.
-
9何礼贤.喜读《实用抗感染药物手册》[J].中华结核和呼吸杂志,2003,26(2):128-128.
-
10张鲜利,霍花.在药房实践中解读《新编药物学(第16版)》[J].药学实践杂志,2008,26(5):387-388. 被引量：1
